Source comparison
Stacking KPV BPC-157 IBD Research: A Practical Comparison
TNBS-induced colitis (rats) 1.0 10 KPV SubQ / BPC-157 IP 68% ulcer area reduction vs 42% BPC-157 alone Additive anti-inflammatory and repair effects demonstrated. Strongest evidence for stacking DSS-induced colitis (mice) 0.5 Both IP 54% lower bacterial transl
This comparison does not assign a generated winner or score.
- TNBS-induced colitis (rats)
- 1.0
- 10
- KPV SubQ / BPC-157 IP
- 68% ulcer area reduction vs 42% BPC-157 alone
- Additive anti-inflammatory and repair effects demonstrated. Strongest evidence for stacking
- DSS-induced colitis (mice)
- 0.5
- Both IP
- 54% lower bacterial translocation vs 31% BPC-157 monotherapy
- Barrier restoration enhanced when both peptides administered. Confirms non-redundant pathways
- Acetic acid colitis (rats)
- 2.0
- 15
- KPV SubQ / BPC-157 oral
- 47% faster re-epithelialization rate
- Oral BPC-157 still effective when stacked. Practical for human translation
- Chronic relapsing colitis (IL-10 knockout mice)
- Both SubQ
- 62% reduction in histological inflammation score
- Long-term stacking maintained efficacy without tolerance. No diminishing returns observed